The landscape of diabetes care is changing with the arrival of GLP-1 patches . These innovative devices offer a likely simpler alternative to shots for individuals living with type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the dermis , avoiding the need for frequent injections and perhaps increasing compliance . Preliminar